Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/N1VO34 stock hub

BVMF/N1VO34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/N1VO34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

992.9B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/N1VO34

In the news

Latest news · BVMF/N1VO34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.2

P25 11.3P50 14.6P75 19.6

Trailing P/E10.1

P25 15.2P50 21.5P75 27.3

ROE71.4

P25 5.3P50 12.3P75 22.5

ROIC40.4

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/N1VO34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

DKK

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	BR
Employees	67,900
Employees Change	-7,844%
Employees Change Percent	-10.14
Enterprise value	BRL 1.1T
Exchange	Brazil Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 992.9B
Price	BRL 28.02
Price currency	BRL
Rev Per Employee	3,885,229.72x
Sector	Healthcare
Sic	2834
Symbol	bvmf/N1VO34
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.89%
EV Earnings	11.1x
EV/EBIT	8.74x
EV/EBITDA	8.04x
EV/FCF	22.4x
EV/Sales	4.31x
FCF yield	4.9%
Forward P/E	14.16x
P/B ratio	6.08x
P/E ratio	10.12x
P/S ratio	3.76x
PE Ratio10 Y	25.85x
PE Ratio3 Y	28.73x
PE Ratio5 Y	30.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.25%
EBITDA Margin	53.04%
FCF margin	18.43%
Gross margin	83.2%
Gross Profit	BRL 219.5B
Gross Profit Growth	6.28%
Gross Profit Growth Q	27.65%
Gross Profit Growth3 Y	19.81%
Gross Profit Growth5 Y	20.91%
Net Income	BRL 98.1B
Net Income Growth	16.58%
Net Income Growth Q	67.24%
Net Income Growth3 Y	25.89%
Net Income Growth5 Y	23.26%
Pretax Margin	47.49%
Profit Margin	37.2%
Profit Per Employee	BRL 1.4M
ROA	19.25
Roa5y	21.35
ROCE	48.33
ROE	71.4
Roe5y	74.56
ROIC	40.42
Roic5y	68.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-41.34%
Cagr3y	-16.16%
Div CAGR3	22.26%
EPS Growth	16.75
EPS Growth Q	67.08
EPS Growth3 Y	26.65
EPS Growth5 Y	24.4
FCF Growth	-23.77%
FCF Growth Q	12.96%
FCF Growth3 Y	-4.69%
FCF Growth5 Y	4.87%
OCF Growth	-9.84%
OCF Growth Q	-2.61%
OCF Growth10 Y	11.02%
OCF Growth3 Y	11.65%
OCF Growth5 Y	17.37%
Revenue Growth	8.13x
Revenue Growth Q	23.99x
Revenue Growth3 Y	20.3x
Revenue Growth5 Y	20.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.63
Assets	BRL 450.1B
Cash	BRL 17.4B
Current Assets	BRL 137.4B
Current Liabilities	BRL 174.5B
Debt	BRL 117.8B
Debt EBITDA	BRL 0.83
Debt Equity	BRL 0.72
Debt FCF	BRL 2.42
Equity	BRL 163.4B
Interest Coverage	38.38
Liabilities	BRL 286.6B
Long Term Assets	BRL 312.6B
Long Term Liabilities	BRL 112.1B
Net Cash	BRL -100.4B
Net Cash By Market Cap	BRL -10.11
Net Debt EBITDA	BRL 0.72
Net Debt Equity	BRL 0.61
Net Debt FCF	BRL 2.06
Tangible Book Value	BRL 58.9B
Tangible Book Value Per Share	BRL 13.25
WACC	5.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Inventory Turnover	1.17
Net Working Capital	BRL -34B
Quick ratio	0.54
Working Capital	BRL -38.5B
Working Capital Turnover	BRL -4.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.2%
Dividend Growth	-3.96%
Dividend Growth Years	4%
Dividend per share	BRL 0.81
Dividend Years	5
Dividend Yield	2.85%
Ex Div Date	2026-03-27
Last Dividend	BRL 0.54
Payout Frequency	Semi-Annual
Payout Ratio	42.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-41.31%
200-day SMA	33.33
3Y total return	-41.08%
50-day SMA	24.94
50-day SMA vs 200-day SMA	50under200
All Time High	103.1
All Time High Change	-72.73%
All Time High Date	2024-07-01
All Time Low	22.9
All Time Low Change	22.79%
All Time Low Date	2026-03-30
ATR	0.87
Beta	0.35
Ch YTD	-21.85
High	28.43
High52	57.25
High52 Date	2025-06-13
High52ch	-51.06%
Low	27.67
Low52	22.9
Low52 Date	2026-03-30
Low52ch	22.36%
Ma50ch	12.77%
Price vs 200-day SMA	-15.64%
RSI	65.85
RSI Monthly	37.19
RSI Weekly	42.84
Sharpe ratio	-0.71x
Sortino ratio	-0.8
Total Return	3.05%
Tr YTD	-19.91
Tr1m	18.8%
Tr1w	2.14%
Tr3m	-7.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 129.9B
Operating Income Growth	10.7
Operating Income Growth Q	53.69
Operating Income Growth3 Y	25.63
Operating Income Growth5 Y	24.88
Operating margin	49.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,179,265,266%
Net Borrowing	18,723,160,904.7
Shares Insiders	0.02%
Shares Institutions	28.04%
Shares Qo Q	-0.02%
Shares Yo Y	-0.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 47.5B
Average Volume	30,985.15x
Bv Per Share	36.79
CAPEX	BRL -46.7B
Ch1m	18.8
Ch1w	2.14
Ch1y	-43.18
Ch3m	-9.73
Ch3y	-44.24
Ch6m	-7.07
Change	-1.37%
Change From Open	-1.44
Close	28.41
Days Gap	0.07
Depreciation Amortization	9,634,789,634.7
Dollar Volume	405,533.5
Earnings Date	2026-05-06
EBIT	BRL 129.9B
EBITDA	BRL 139.9B
EPS	BRL 22.06
F Score	4
FCF	BRL 48.6B
FCF EV Yield	4.47x
Financing CF	-40,608,426,919
Fiscal Year End	December
Founded	1,923
Goodwill	15,405,897,640.5
Graham Number	17.01419
Graham Upside	-39.49
Income Tax	BRL 27.1B
Investing CF	-68,318,634,329
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2023-09-20
Last Split Type	Forward
Lynch Fair Value	BRL 64.66
Lynch Upside	129.9
Ma150	31.73
Ma150ch	-11.37%
Ma20	25.67
Ma20ch	9.53%
Net CF	-14,333,948,193
Next Earnings Date	2026-08-05
Open	28.43
P FCF Ratio	20.42
P OCF Ratio	10.42
Payment Date	2026-04-14
Position In Range	46.05
Ppne	170,493,380,670
Price Date	2026-05-08
Price EBITDA	BRL 7.1
Ptbv Ratio	16.86
Relative Volume	0.47x
Revenue	263,807,097,726x
SBC By Revenue	0.44x
Share Based Comp	1,154,860,236
Tax By Revenue	10.29x
Tax Rate	21.66%
Tr6m	-4.77%
Volume	14,473
Z Score	4.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/N1VO34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.9%

$0.81 annual per share

Payout ratio

+42.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

4 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2026-03-27

Performance

BVMF/N1VO34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/N1VO34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.0%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

BVMF/N1VO34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.8

Neutral momentum band

Price vs 200-day MA

-15.6%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

-0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/N1VO34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/N1VO34 stock rating?

bvmf/N1VO34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/N1VO34 analysis?

The full report lives at /stocks/bvmf/N1VO34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/N1VO34?

The latest report frames bvmf/N1VO34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/N1VO34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.